AzTrials
AzTrials

Neck Pain ChronicNCT06996210

Effect of Acupuncture on Chronic Nonspecific Neck Pain and Insomnia

A study testing Acupuncture in people with Neck Pain Chronic and Insomnia Chronic, run by Guang'anmen Hospital of China Academy of Chinese Medical Sciences.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The study aims to assess the efficacy and safety of acupuncture among patients with chronic nonspecific neck pain and insomnia, compared with sham acupuncture. Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Neck Pain Chronic, Insomnia Chronic
What is being tested?
Acupuncture
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
124 participants
Where
No sites listed yet
Study dates
1 Sep 2025to 27 Mar 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Aged 18 to 75 years old;
  • Meet the diagnostic criteria for both chronic nonspecific neck pain and chronic insomnia;
  • The patient's average 24-hour overall neck pain intensity score on the NRS is ≥3;
  • The patient's Insomnia Severity Index (ISI) score is ≥10;
  • The patient is willing to participate in the study and has signed the informed consent form.

Who cannot join

  • Specific neck pain with a clear etiology, including trauma, tumor, connective tissue disease, rheumatic disease, metabolic and endocrine disorders, neuropathy, spinal cord disease, fracture, or vertebral misalignment;
  • Positive Spurling test, neck flexion test, upper limb traction test, or foraminal distraction test. Neck pain accompanied by radiating pain in the upper limbs or radicular compression symptoms, or acute exacerbation of neck pain;
  • Neck pain accompanied by sensory disturbances or other neurological symptoms, or ankylosis of the facet joints;
  • Previous history of cervical spine surgery;
  • Previous history of head and neck trauma, such as whiplash injury;
  • Insomnia caused by medications (e.g., caffeine, corticosteroids), withdrawal reactions, or other underlying conditions (e.g., hyperthyroidism, severe anxiety/depressive disorders);
Show all 13Show fewer
  • Long-term use of analgesics, muscle relaxants, or hormones, or presence of other pain more severe than neck pain;
  • Other sleep disorders, such as sleep apnea syndrome, or shift workers;
  • Presence of psychiatric disorders (e.g., depression), cognitive impairment, or language disorders;
  • Patients with drug dependency;
  • Received acupuncture treatment within the past month;
  • Severe cardiovascular, hepatic, renal, hematologic, autoimmune diseases, infectious diseases, poor general nutritional status, malignancy, or patients in the terminal stage of severe illness;
  • Pregnant or planning to become pregnant within the next year, breastfeeding, or postpartum ≤12 months.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

About this study

Official title: Efficacy of Acupuncture in Treating Comorbid Chronic Nonspecific Neck Pain and Insomnia

The study aims to assess the efficacy and safety of acupuncture among patients with chronic nonspecific neck pain and insomnia, compared with sham acupuncture.

Being tested
Acupuncture, sham acupuncture
Medical subject headings
Sleep Initiation and Maintenance Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AcupunctureDevice

    The needles will be inserted to 12.5-30 mm in acupoints through adhesive pads. Needles will be lifted, thrusted and twirled gently for 3 times to achieve deqi sensation and manipulated every ten minutes.

  • sham acupunctureDevice

    The needle will be inserted to 2-3mm in sham Baihui acupoint. For the remaining sham acupoints, needles will be inserted into the pad and reaching the skin. Needles will be lifted, thrusted and twirled gently for 3 times to simulate the effect of the needle tip penetrating the skin.

Study groups in NCT06996210
Study groupRoleWhat they receive
acupuncture groupExperimentalParticipants in the acupuncture group will receive treatment at DU 20 [Baihui], EX-HN15 [Jingbailao], GB 12 [Wangu], Shangyintang (On the head, 1 B-cun superior to Yintang), HT7 [Shenmen], KI 3 [Taixi] and Ashi Point. The treatment will last 30 minutes for each session, 3 sessions per week (ideally every other day) for a succession of 4 weeks.
Receives: Device: Acupuncture
Sham acupuncture (SA) groupSham comparatorParticipants in the SA group will receive treatment at sham DU 20, sham EX-sham HN15, sham GB 12, sham Shangyintang , sham HT7 and sham KI 3. The treatment will last 30 minutes for each session, 3 sessions per week (ideally every other day) for a succession of 4 weeks.
Receives: Device: sham acupuncture

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The change in average 24h overall neck pain intensity measured by NRS from baseline over the past week

    The NRS score ranges from 0 to 10, with higher scores indicating more severe pain.

    Measured: week 5

  2. The change from baseline in the Chinese version of the Insomnia Severity Index (ISI-C) scores.

    The Chinese version of the Insomnia Severity Index (ISI-C) will be used to assess the severity of patients' self-perceived insomnia symptoms. Each item is rated on a scale from 0 to 4, with a total score ranging from 0 to 28. Based on the total score, the severity of insomnia can be categorized into four levels: a score of 0-7 indicates "no clinically significant insomnia," 8-14 indicates "subclinical insomnia," 15-21 indicates "clinical insomnia (moderate)," and 22-28 indicates "clinical insomnia (severe)."

    Measured: week 5

Secondary outcomes (13)
  1. The change in average 24h overall neck pain intensity measured by NRS from baseline over the past week

    The NRS score ranges from 0 to 10, with higher scores indicating more severe pain.

    Measured: week 9 and 16

  2. The change from baseline in the ISI-C scores.

    The ISI-C will be used to assess the severity of patients' self-perceived insomnia symptoms. Each item is rated on a scale from 0 to 4, with a total score ranging from 0 to 28. Based on the total score, the severity of insomnia can be categorized into four levels: a score of 0-7 indicates "no clinically significant insomnia," 8-14 indicates "subclinical insomnia," 15-21 indicates "clinical insomnia (moderate)," and 22-28 indicates "clinical insomnia (severe)."

    Measured: week 9 and 16

  3. The proportion of participants with at least 30% reduction in NRS scores from baseline

    The NRS score ranges from 0 to 10, with higher scores indicating more severe pain.

    Measured: week 5, 9 and 16

  4. The proportion of participants with at least 6 points reduction in ISI-C scores from baseline

    The ISI-C will be used to assess the severity of patients' self-perceived insomnia symptoms. Each item is rated on a scale from 0 to 4, with a total score ranging from 0 to 28. Based on the total score, the severity of insomnia can be categorized into four levels: a score of 0-7 indicates "no clinically significant insomnia," 8-14 indicates "subclinical insomnia," 15-21 indicates "clinical insomnia (moderate)," and 22-28 indicates "clinical insomnia (severe)."

    Measured: week 5, 9 and 16

  5. The change from baseline in the total score of the Neck Disability Index (NDI).

    Neck Disability Index (NDI) consists of 10 items, with a total score ranging from 0 to 50. A higher score indicates a greater impact of neck pain on quality of life.

    Measured: week 5, 9 and 16

  6. The proportion of participants with at least 10 points reduction in NDI scores from baseline

    NDI consists of 10 items, with a total score ranging from 0 to 50. A higher score indicates a greater impact of neck pain on quality of life.

    Measured: week 5, 9 and 16

  7. The change from baseline in the maximum pain intensity score on the NRS during six directions of neck movement.

    The NRS score ranges from 0 to 10, with higher scores indicating more severe pain.

    Measured: week 5, 9 and 16

  8. The change from baseline in the Pittsburgh Sleep Quality Index (PSQI).

    The PSQI has a total score ranging from 0 to 21. A higher score indicates poorer sleep quality. Specifically, a total score of 0-5 indicates very good sleep quality; 6-10 indicates fairly good sleep quality; 11-15 indicates average sleep quality; and 16-21 indicates poor sleep quality.

    Measured: week 5, 9 and 16

  9. The change from baseline in the Hospital Anxiety and Depression Scale (HADS) scores.

    The HADS score ranges from 0 to 42, with higher scores indicating greater anxiety and depression.

    Measured: week 5, 9 and 16

  10. The proportion of responders per the Patient Global Impression of Change (PGI-C)

    The PGI-C evaluates the overall treatment effect perceived by patients themselves. The change can be rated in 7 levels, including "very much better", "moderately better, "a little better", "no change", "a little worse", "moderately worse" or "very much worse".

    Measured: week 5 and 16

  11. The percentage of patients who used rescue analgesics and sedative-hypnotics.

    The percentage of patients who used emergency analgesics and sedative-hypnotics.

    Measured: week 5, 9 and 16

  12. The total number of days of using rescue analgesics and sedative-hypnotics.

    The total number of days of using rescue analgesics and sedative-hypnotics.

    Measured: week 5, 9 and 16

  13. Blinding assessment

    In this trial, two types of acupuncture treatments were used: traditional acupuncture, which has a stronger sensation of needle insertion, and modern acupuncture, which has a weaker sensation of needle insertion. Patients were asked which type of therapy they thought they had received.

    Measured: Within 5 minutes after the last treatment at week 4.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 May 2025
  2. Study start1 Sep 2025 (estimated)
  3. Primary completion27 Dec 2027 (estimated)
  4. Study completion27 Mar 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
124 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06996210
Sponsor's protocol ID
2025-090-KY
Status last verified
Jul 2025
First submitted
14 May 2025
Last updated
15 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Deidentified participant data and data dictionary will be available with the publication until six months after publication. A formal request should be sent to zhishunjournal@163.com with a methodologically sound proposal. Researchers whose proposal has been approved will sign a data access agreement.

Publications

  • Liu S, Chen H, Shen X, Lun H, Fan J, Wang W, Shi G, Liu Z. Acupuncture for Comorbid Chronic Nonspecific Neck Pain and Chronic Insomnia: Protocol for a Multicenter, Randomized, Sham-Controlled Trial. J Pain Res. 2026 Apr 17;19:598575. doi: 10.2147/JPR.S598575. eCollection 2026.

    PubMed 42110592

Questions about this trial

What is this clinical trial studying?

A study testing Acupuncture in people with Neck Pain Chronic and Insomnia Chronic, run by Guang'anmen Hospital of China Academy of Chinese Medical Sciences.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 15 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Zhishun Liu (+861088002331, zhishunjournal@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The change in average 24h overall neck pain intensity measured by NRS from baseline over the past week (time frame: week 5). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06996210, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in